Skip to main content
. 2013 Nov;52(6):782–791.

Table 2.

Incidence rate (CPM) and percentage of clinical cases for each disease

Incidence rate (CPM)
Facility A Facility B Facility C Facility D Overall 95% confidence interval % of clinical cases
Nonspecific systemic diseases Spontaneous mortality with unknown cause—adults 30.21 ± 0.48 (27.66–33.71) 16.01 ± 1.14 (10.20–23.13) 28.15 ± 1.01 (22.17–35.49) 33.50 ± 1.37 (25.10–41.25) 27.13 ± 0.54 (24.18–31.68) 25.95–28.31
Spontaneous mortality with unknown cause—pups 39.88 ± 2.82 (21.54–51.39) 2.21 ± 0.56 (0.34–7.33) 1.80 ± 0.28 (0.12–3.42) 18.83 ± 2.95 (3.17–36.43) 17.72 ± 1.08 (11.43–23.96) 15.36–20.08
Lethargy, poor haircoat, etc 1.49 ± 0.24 (0.80–4.38) 0.32 ± 0.10 (0.00–1.27) 0.99 ± 0.15 (0.13–1.83) 3.63 ± 0.33 (1.86–6.11) 1.49 ± 0.13 (1.01–2.76) 1.21–1.77 11.0
Muscle wasting 0.73 ± 0.11 (0.22–1.46) 0.16 ± 0.05 (0.00–0.65) 0.78 ± 0.11 (0.13–1.60) 1.94 ± 0.32 (0.58–4.69) 0.79 ± 0.08 (0.36–1.28) 0.61–0.97 5.6
Moribund 0.24 ± 0.03 (0.10–0.44) 0.18–0.30 1.8
Dermatitis All anatomic locations 2.51 ± 0.17 (1.43–3.33) 1.75 ± 0.17 (0.51–2.98) 1.97 ± 0.19 (0.57–3.20) 9.08 ± 0.67 (5.66–12.97) 3.11 ± 0.12 (2.57–4.02) 2.85–3.37 21.7
Ulcerative dermatitis and dermatitis of dorsal neck and pinnas 1.42 ± 0.13 (0.55–2.12) 1.14 ± 0.14 (0.51–2.10) 0.85 ± 0.13 (0.23–1.59) 4.69 ± 0.60 (1.62–8.83) 1.65 ± 0.09 (1.17–2.30) 1.46–1.84
Face, muzzle, and nose 0.51 ± 0.07 (0.18–0.84) 0.20 ± 0.05 (0.00–0.67) 0.29 ± 0.07 (0.00–0.68) 1.57 ± 0.24 (0.58–3.42) 0.52 ± 0.04 (0.30–0.84) 0.44–0.60
Back and flanks 0.21 ± 0.07 (0.00–0.83) 0.15 ± 0.06 (0.00–0.53) 0.30 ± 0.06 (0.11–0.77) 1.24 ± 020 (0.00–2.20) 0.37 ± 0.03 (0.17–0.54) 0.30–0.44
Hindlimbs 0.17 ± 0.02 (0.00–0.26) 0.13–0.21
Ventral neck 0.12 ± 0.02 (0.00–0.20) 0.08–0.16
Base of tail and tail 0.11 ± 0.02 (0.00–0.26) 0.05–0.17
Fight wounds Fight wounds 2.21 ± 0.06 (1.66–2.50) 1.23 ± 0.14 (0.17–2.12) 1.30 ± 0.16 (0.34–2.39) 4.81 ± 0.54 (1.56–8.28) 2.10 ± 0.06 (1.66–2.50) 1.97–2.23 14.7
Ocular lesions Eye 0.73 ± 0.13 (0.10–1.85) 0.31 ± 0.07 (0.00–0.56) 0.99 ± 0.27 (0.11–3.20) 4.73 ± 0.13 (1.01–2.76) 1.28 ± 0.13 (0.67–2.04) 1.00–1.56 8.9
Female reproductive and neonatal diseases Dystocia 0.81 ± 0.08 (0.30–1.50) 0.04 ± 0.03 (0.00–0.57) 0.19 ± 0.05 (0.00–0.57) 0.57 ± 0.09 (0.00–1.39) 0.43 ± 0.04 (0.24–0.68) 0.35–0.51 3.0
Neonates with clinical disease 0.86 ± 0.08 (0.30–1.29) 0.11 ± 0.04 (0.00–0.35) 0.13 ± 0.03 (0.00–0.34) 0.76 ± 0.12 (0.23–1.72) 0.48 ± 0.02 (0.34–0.62) 0.43–0.53 3.3
Prolapsed vagina or uterus 0.14 ± 0.03 (0.03–0.40) 0.08–0.20 1.0
Tumors Tumors 0.72 ± 0.10 (0.19–1.54) 0.34 ± 0.07 (0.00–0.69) 0.63 ± 0.14 (0.13–1.94) 3.08 ± 0.48 (1.08–6.35) 0.94 ± 0.08 (0.47–1.45) 0.76–1.12 6.5
Malocclusion Malocclusion 0.35 ± 0.05 (0.09–0.64) 0.14 ± 0.04 (0.00–0.42) 1.19 ± 0.19 (0.46–3.31) 0.98 ± 0.17 (0.00–1.95) 0.65 ± 0.06 (0.44–1.24) 0.53–0.77 4.5
Prolapsed rectum Prolapsed rectum 0.70 ± 0.06 (0.27–1.02) 0.17 ± 0.06 (0.00–0.73) 0.36 ± 0.06 (0.11–0.84) 1.03 ± 0.15 (0.00–1.72) 0.54 ± 0.04 (0.34–0.83) 0.46–0.62 3.7
Iatrogenic disease Watering failures 0.23 ± 0.03 (0.03–0.44) 0.16–0.30 1.7
Iatrogenic lameness 0.07 0.5
Neurologic disease Head tilt 0.29 ± 0.04 (0.00–0.57) 0.20–0.38 2.1
Paresis, paralysis 0.18 ± 0.02 (0.03–0.27) 0.14–0.22 1.3
Hydrocephalus 0.17 ± 0.03 (0.03–0.40) 0.11–0.23 1.2
Ataxia 0.05 <1
Male urogenital diseases Prolapsed penis 0.20 ± 0.03 (0.03–0.36) 0.13–0.27 1.5
Preputial gland disease 0.12 ± 0.02 (0.00–0.30) 0.07–0.17 <1
Miscellaneous Secondary Enterobacter infections in immunosuppressed mice 0.28 ± 0.10 (0.00–1.11) 0.07–0.49 2.0
Distended abdomen, ascites 0.15 ± 0.02 (0.04–0.37) 0.10–0.20 1.1
Lame 0.14 ± 0.04 (0.00–0.27) 0.05–0.23 1.1
Abscesses (not involving the preputial gland) 0.07 <1
Perineal hernia or scrotal disease 0.06 <1
Respiratory disease 0.05 <1

Data are presented as mean ± SE (range). Diseases reported more than 120 times were analyzed by both facility and month. Diseases reported between 40 and 120 times were analyzed by month, with all of the facilities pooled. Diseases reported fewer than 40 times were analyzed as cases during the year by total number of cages in all 4 facilities.